Serum C18-ceramide as a biomarker for response: Phase II trial of gemcitabine plus doxorubicin in patients with HNSCC.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: K. Shirai, S. Saddoughi, P. E. O'Brien, L. Afrin, E. Garrett-Mayer, G. R. Simon, U. B. Chaudhary, B. Ogretmen
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2563235791